These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7507413

  • 1. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643.
    Marsman DS, Popp JA.
    Carcinogenesis; 1994 Jan; 15(1):111-7. PubMed ID: 7507413
    [Abstract] [Full Text] [Related]

  • 2. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC, Popp JA.
    Cancer Res; 1989 Jun 15; 49(12):3246-51. PubMed ID: 2566380
    [Abstract] [Full Text] [Related]

  • 3. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
    Miller RT, Cattley RC, Marsman DS, Lyght O, Popp JA.
    Carcinogenesis; 1995 Jan 15; 16(1):77-82. PubMed ID: 7530605
    [Abstract] [Full Text] [Related]

  • 4. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.
    Cattley RC, Marsman DS, Popp JA.
    Carcinogenesis; 1991 Mar 15; 12(3):469-73. PubMed ID: 1849052
    [Abstract] [Full Text] [Related]

  • 5. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643.
    Rose ML, Cattley RC, Dunn C, Wong V, Li X, Thurman RG.
    Carcinogenesis; 1999 Nov 15; 20(11):2075-81. PubMed ID: 10545408
    [Abstract] [Full Text] [Related]

  • 6. The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643.
    Rao MS, Lalwani ND, Scarpelli DG, Reddy JK.
    Carcinogenesis; 1982 Nov 15; 3(10):1231-3. PubMed ID: 6129072
    [Abstract] [Full Text] [Related]

  • 7. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
    Moser GJ, Wolf DC, Goldsworthy TL.
    Toxicol Pathol; 1997 Nov 15; 25(3):275-83. PubMed ID: 9210259
    [Abstract] [Full Text] [Related]

  • 8. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
    Kraupp-Grasl B, Huber W, Taper H, Schulte-Hermann R.
    Cancer Res; 1991 Jan 15; 51(2):666-71. PubMed ID: 1985784
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas.
    Miller RT, Anderson SP, Corton JC, Cattley RC.
    Carcinogenesis; 2000 Apr 15; 21(4):647-52. PubMed ID: 10753199
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
    Lake BG, Evans JG, Cunninghame ME, Price RJ.
    Environ Health Perspect; 1993 Dec 15; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
    [Abstract] [Full Text] [Related]

  • 11. Dose-dependent induction of carcinomas and glutathione S-transferase placental form negative eosinophilic foci in the rat liver by di(2-ethylhexyl)phthalate after diethylnitrosamine initiation.
    Sano M, Hagiwara A, Tamano S, Hasegawa R, Imaida K, Ito N, Shirai T.
    J Toxicol Sci; 1999 Aug 15; 24(3):177-86. PubMed ID: 10478332
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
    Biegel LB, Hurtt ME, Frame SR, O'Connor JC, Cook JC.
    Toxicol Sci; 2001 Mar 15; 60(1):44-55. PubMed ID: 11222872
    [Abstract] [Full Text] [Related]

  • 14. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
    Ohshima M, Ward JM, Brennan LM, Creasia DA.
    J Natl Cancer Inst; 1984 Mar 15; 72(3):759-68. PubMed ID: 6583458
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
    Hayashi F, Tamura H, Yamada J, Kasai H, Suga T.
    Carcinogenesis; 1994 Oct 15; 15(10):2215-9. PubMed ID: 7955056
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.
    Peters JM, Cattley RC, Gonzalez FJ.
    Carcinogenesis; 1997 Nov 15; 18(11):2029-33. PubMed ID: 9395198
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
    Marsman DS, Goldsworthy TL, Popp JA.
    Carcinogenesis; 1992 Jun 15; 13(6):1011-7. PubMed ID: 1600604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.